News & Events zu argenx SE (ARGX)

$1,023.210

-34.482 (-3.37%)Zum Schluss

ARGX-News

6.008-26CNBC

Latest Ratings and Outlook from Wall Street

9.008-26NASDAQ.COM

Argenx Achieves Phase 3 Success for Vyvgart Hytrulo in Autoimmune Myositis

2.008-26Fool

Argenx's Vyvgart Hytrulo Shows Positive Phase 3 Results for Autoimmune Myositis

7.508-24NASDAQ.COM

Biotech Stocks Reach 52-Week Highs Amid Positive Trials

8.508-17Newsfilter

Zai Lab and argenx Announce Positive ALKIVIA Study Results

9.008-17NASDAQ.COM

argenx SE's ALKIVIA Trial Achieves Primary Endpoint Success

2.008-17Newsfilter

argenx ALKIVIA Study Achieves Positive Results

9.508-10NASDAQ.COM

Halozyme Reports Increased Net Income in Q2

6.507-31CNBC

Investors Increase Exposure to International Equities

8.507-29Yahoo Finance

argenx Acquires Forte Biosciences for $2.2 Billion

Mehr News anzeigen

ARGX-Events

8/17 12:30

Argenx Shares Rise 16.6%

Argenx is up 16.6%, or…

8/17 10:30

Argenx Shares Rise 14.9%

Argenx is up 14.9%, or…

8/17 06:30

Zai Lab Partners with argenx for Strategic Collaboration

Zai Lab (ZLAB) and argenx…

Mehr Events anzeigen

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.